Sight Sciences
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2011-01-01
- Employees
- 214
- Market Cap
- -
- Website
- http://www.sightsciences.com
- Introduction
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
OMNI® Surgical System Shows Long-Term Efficacy in Comprehensive 22-Study Meta-Analysis for Glaucoma Treatment
• Meta-analysis of 22 studies demonstrates significant long-term intraocular pressure reduction and decreased medication dependence using the OMNI® Surgical System for glaucoma treatment.
• Real-world data from the IRIS® Registry confirms sustained effectiveness of standalone canaloplasty and trabeculotomy procedures over 36 months in primary open-angle glaucoma patients.
• New analysis from the ROMEO Study reveals OMNI® achieves comparable pressure and medication reductions across mild, moderate, and advanced glaucoma cases.
© Copyright 2025. All Rights Reserved by MedPath